Speculatively, we propose that these phenomena could attenuate or amplify the effect of agonistic agents in different cancer cell lines, as we observed in the present report comparing the effect of agonistic agents in targeting EphA2 in MDA-MB-231 or BxPC3. Here, EPHA2 is linked to cancer.